Understanding the effect of obesity on papillary thyroid cancer: is there a need for tailored diagnostic and therapeutic management?. Issue 6 (2nd November 2022)

• Record Type: Journal Article
• Authors: Matrone, Antonio; Basolo, Alessio; Santini, Ferruccio; Elisei, Rossella
• Is Part Of: Expert review of endocrinology & metabolism. Volume 17:Issue 6(2022)
• Page Start: 475
• Page End: 484
• Publication Date: 2022-11-02
• Subjects: Body mass index -- obesity -- differentiated thyroid cancer -- papillary thyroid cancer -- aggressive histology -- management of thyroid cancer in obesity; Endocrinology -- Periodicals; Metabolism -- Periodicals; 616.4
• DOI: 10.1080/17446651.2022.2131529
• Languages: English
• ISSNs: 1744-6651

Abstract

ABSTRACT: Introduction: Several studies have focused on the relationship between obesity and differentiated thyroid carcinoma (DTC), particularly papillary histotype (PTC). However, the association of obesity with both incidence and aggressiveness of PTC is still incompletely understood. Areas covered: We reviewed the mechanisms underlying the cross talk between obesity and thyroid carcinomas and described the most recent evidence evaluating the effect of obesity on the development of PTC, as well as the impact of excessive body weight on the clinicopathologic features and outcome of this type of cancer. Expert opinion: Available evidence suggests that excessive body weight is linked with a higher risk of getting PTC, while its impact on the aggressiveness of the disease, if present, is still not clear. Therefore, while attention should be paid to discover thyroid cancer in patients with obesity earlier, once diagnosed it should be managed following a conventional workup as in normal weight patients, based on the clinical presentation of the disease and including active surveillance if appropriate, as recommended by referral guidelines.